Disease Info Card

Testicular Germ Cell Tumor

Information about Testicular Germ Cell Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Testicular Germ Cell Tumor

Most recent studies have shown that Testicular Germ Cell Tumor shares some biological mechanisms with carcinoma, carcinoma-in-situ, cell-transformation-neoplastic, choriocarcinoma, cryptorchidism, dysgerminoma, embryonal-carcinoma, germ-cell-tumor, germ-cell-tumor-nonseminomatous, germinoma, malignant-neoplasm-of-testis, malignant-neoplasms, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, neoplasms-germ-cell-and-embryonal, neoplasms-multiple-primary, seminoma, teratoma, testicular-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Testicular Germ Cell Tumor, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Development, Cell Differentiation, Cell Growth, Cell Proliferation, Dna Methylation, Drug Resistance, Germ Cell Development, Hypersensitivity, Induction Of Apoptosis, Interphase, Localization, Metaphase, Methylation, Oncogenesis, Pathogenesis, Secretion, Spermatogenesis

Quite a number of genes have been found to play important roles in Testicular Germ Cell Tumor, such as AFP, AR, BAK1, CDKN1A, CDKN2A, CISH, DND1, EPO, FAS, KIT, KITLG, KRAS, NANOG, NANOGP8, NSG1, POU5F1, TCEAL1, TP53, TRIM26. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.